nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Azoospermia—Procarbazine—brain cancer	0.0481	0.128	CcSEcCtD
Fluoxymesterone—Oligospermia—Hydroxyurea—brain cancer	0.0478	0.127	CcSEcCtD
Fluoxymesterone—Azoospermia—Hydroxyurea—brain cancer	0.0372	0.0991	CcSEcCtD
Fluoxymesterone—Clotting—Temozolomide—brain cancer	0.0219	0.0584	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Procarbazine—brain cancer	0.0147	0.0393	CcSEcCtD
Fluoxymesterone—PRLR—brain—brain cancer	0.0134	0.0799	CbGeAlD
Fluoxymesterone—SHBG—hindbrain—brain cancer	0.0126	0.0752	CbGeAlD
Fluoxymesterone—Gynaecomastia—Procarbazine—brain cancer	0.0116	0.0309	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Hydroxyurea—brain cancer	0.0114	0.0304	CcSEcCtD
Fluoxymesterone—Haemoglobin—Lomustine—brain cancer	0.0103	0.0274	CcSEcCtD
Fluoxymesterone—Haemorrhage—Lomustine—brain cancer	0.0102	0.0273	CcSEcCtD
Fluoxymesterone—Coagulopathy—Temozolomide—brain cancer	0.0101	0.0268	CcSEcCtD
Fluoxymesterone—ESR1—blood vessel—brain cancer	0.0093	0.0555	CbGeAlD
Fluoxymesterone—Alopecia—Lomustine—brain cancer	0.00905	0.0241	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Temozolomide—brain cancer	0.00891	0.0237	CcSEcCtD
Fluoxymesterone—ESR1—hindbrain—brain cancer	0.00887	0.0529	CbGeAlD
Fluoxymesterone—Gynaecomastia—Carmustine—brain cancer	0.00725	0.0193	CcSEcCtD
Fluoxymesterone—SHBG—brainstem—brain cancer	0.00721	0.0431	CbGeAlD
Fluoxymesterone—NR3C1—hindbrain—brain cancer	0.00654	0.0391	CbGeAlD
Fluoxymesterone—Haemoglobin—Procarbazine—brain cancer	0.00653	0.0174	CcSEcCtD
Fluoxymesterone—Haemorrhage—Procarbazine—brain cancer	0.0065	0.0173	CcSEcCtD
Fluoxymesterone—Alopecia—Procarbazine—brain cancer	0.00575	0.0153	CcSEcCtD
Fluoxymesterone—SHBG—gonad—brain cancer	0.00534	0.0319	CbGeAlD
Fluoxymesterone—SHBG—pituitary gland—brain cancer	0.00521	0.0311	CbGeAlD
Fluoxymesterone—ESR1—brainstem—brain cancer	0.00508	0.0303	CbGeAlD
Fluoxymesterone—Haemoglobin—Hydroxyurea—brain cancer	0.00506	0.0135	CcSEcCtD
Fluoxymesterone—Haemorrhage—Hydroxyurea—brain cancer	0.00503	0.0134	CcSEcCtD
Fluoxymesterone—Anxiety—Procarbazine—brain cancer	0.0048	0.0128	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Etoposide—brain cancer	0.0047	0.0125	CcSEcCtD
Fluoxymesterone—AR—telencephalon—brain cancer	0.00459	0.0274	CbGeAlD
Fluoxymesterone—ESR1—telencephalon—brain cancer	0.00451	0.0269	CbGeAlD
Fluoxymesterone—Alopecia—Hydroxyurea—brain cancer	0.00445	0.0118	CcSEcCtD
Fluoxymesterone—Nausea—Lomustine—brain cancer	0.00432	0.0115	CcSEcCtD
Fluoxymesterone—Paraesthesia—Procarbazine—brain cancer	0.00415	0.0111	CcSEcCtD
Fluoxymesterone—Haemoglobin—Carmustine—brain cancer	0.00409	0.0109	CcSEcCtD
Fluoxymesterone—Haemorrhage—Carmustine—brain cancer	0.00407	0.0108	CcSEcCtD
Fluoxymesterone—SHBG—endocrine gland—brain cancer	0.00404	0.0241	CbGeAlD
Fluoxymesterone—Haemoglobin—Temozolomide—brain cancer	0.00395	0.0105	CcSEcCtD
Fluoxymesterone—Haemorrhage—Temozolomide—brain cancer	0.00393	0.0105	CcSEcCtD
Fluoxymesterone—AR—gonad—brain cancer	0.00383	0.0229	CbGeAlD
Fluoxymesterone—ESR1—gonad—brain cancer	0.00376	0.0225	CbGeAlD
Fluoxymesterone—NR3C1—brainstem—brain cancer	0.00375	0.0224	CbGeAlD
Fluoxymesterone—AR—pituitary gland—brain cancer	0.00374	0.0223	CbGeAlD
Fluoxymesterone—ESR1—pituitary gland—brain cancer	0.00367	0.0219	CbGeAlD
Fluoxymesterone—SHBG—central nervous system—brain cancer	0.00364	0.0217	CbGeAlD
Fluoxymesterone—Alopecia—Carmustine—brain cancer	0.00359	0.00958	CcSEcCtD
Fluoxymesterone—SHBG—cerebellum—brain cancer	0.00356	0.0212	CbGeAlD
Fluoxymesterone—Alopecia—Temozolomide—brain cancer	0.00347	0.00926	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Procarbazine—brain cancer	0.0034	0.00907	CcSEcCtD
Fluoxymesterone—NR3C1—telencephalon—brain cancer	0.00333	0.0199	CbGeAlD
Fluoxymesterone—AR—spinal cord—brain cancer	0.00322	0.0192	CbGeAlD
Fluoxymesterone—Anxiety—Carmustine—brain cancer	0.003	0.00801	CcSEcCtD
Fluoxymesterone—Anxiety—Temozolomide—brain cancer	0.0029	0.00774	CcSEcCtD
Fluoxymesterone—AR—endocrine gland—brain cancer	0.0029	0.0173	CbGeAlD
Fluoxymesterone—Headache—Procarbazine—brain cancer	0.00289	0.00771	CcSEcCtD
Fluoxymesterone—SHBG—brain—brain cancer	0.00289	0.0172	CbGeAlD
Fluoxymesterone—AR—head—brain cancer	0.00286	0.0171	CbGeAlD
Fluoxymesterone—ESR1—endocrine gland—brain cancer	0.00284	0.017	CbGeAlD
Fluoxymesterone—PRLR—Signaling by ERBB4—ERBB2—brain cancer	0.00284	0.00628	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00282	0.00625	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—CTNNB1—brain cancer	0.00281	0.00622	CbGpPWpGaD
Fluoxymesterone—ESR1—head—brain cancer	0.00281	0.0168	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Temozolomide—brain cancer	0.00279	0.00744	CcSEcCtD
Fluoxymesterone—Alopecia—Etoposide—brain cancer	0.00278	0.00741	CcSEcCtD
Fluoxymesterone—NR3C1—gonad—brain cancer	0.00278	0.0166	CbGeAlD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—BRCA2—brain cancer	0.00275	0.00609	CbGpPWpGaD
Fluoxymesterone—Nausea—Procarbazine—brain cancer	0.00274	0.00731	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.00271	0.006	CbGpPWpGaD
Fluoxymesterone—NR3C1—pituitary gland—brain cancer	0.00271	0.0162	CbGeAlD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CCNE1—brain cancer	0.00266	0.00589	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—DTX2—brain cancer	0.00264	0.00585	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Hydroxyurea—brain cancer	0.00263	0.00702	CcSEcCtD
Fluoxymesterone—NR3C1—medulla oblongata—brain cancer	0.00261	0.0156	CbGeAlD
Fluoxymesterone—AR—central nervous system—brain cancer	0.00261	0.0156	CbGeAlD
Fluoxymesterone—Paraesthesia—Carmustine—brain cancer	0.0026	0.00692	CcSEcCtD
Fluoxymesterone—ESR1—central nervous system—brain cancer	0.00256	0.0153	CbGeAlD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IRS2—brain cancer	0.00254	0.00562	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Temozolomide—brain cancer	0.00251	0.00668	CcSEcCtD
Fluoxymesterone—ESR1—cerebellum—brain cancer	0.00251	0.015	CbGeAlD
Fluoxymesterone—PRLR—Adipogenesis—STAT3—brain cancer	0.00245	0.00543	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.00239	0.00529	CbGpPWpGaD
Fluoxymesterone—NR3C1—midbrain—brain cancer	0.00239	0.0143	CbGeAlD
Fluoxymesterone—NR3C1—spinal cord—brain cancer	0.00233	0.0139	CbGeAlD
Fluoxymesterone—Headache—Hydroxyurea—brain cancer	0.00224	0.00597	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Etoposide—brain cancer	0.00223	0.00596	CcSEcCtD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00221	0.00488	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Carmustine—brain cancer	0.00213	0.00567	CcSEcCtD
Fluoxymesterone—Nausea—Hydroxyurea—brain cancer	0.00212	0.00566	CcSEcCtD
Fluoxymesterone—NR3C1—endocrine gland—brain cancer	0.0021	0.0125	CbGeAlD
Fluoxymesterone—AR—brain—brain cancer	0.00207	0.0124	CbGeAlD
Fluoxymesterone—NR3C1—head—brain cancer	0.00207	0.0124	CbGeAlD
Fluoxymesterone—Hypersensitivity—Temozolomide—brain cancer	0.00206	0.00548	CcSEcCtD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CDK4—brain cancer	0.00204	0.00451	CbGpPWpGaD
Fluoxymesterone—ESR1—brain—brain cancer	0.00204	0.0122	CbGeAlD
Fluoxymesterone—Paraesthesia—Etoposide—brain cancer	0.00201	0.00535	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—PTCH2—brain cancer	0.002	0.00443	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—HES1—brain cancer	0.00198	0.00438	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—EGFR—brain cancer	0.00197	0.00435	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—CYP2C9—brain cancer	0.00196	0.377	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—HES5—brain cancer	0.00194	0.00429	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.00192	0.00425	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.0019	0.0042	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—GFAP—brain cancer	0.00189	0.00419	CbGpPWpGaD
Fluoxymesterone—NR3C1—central nervous system—brain cancer	0.00189	0.0113	CbGeAlD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—PDGFRA—brain cancer	0.00189	0.00417	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STRADA—brain cancer	0.00188	0.00417	CbGpPWpGaD
Fluoxymesterone—NR3C1—cerebellum—brain cancer	0.00185	0.011	CbGeAlD
Fluoxymesterone—Headache—Carmustine—brain cancer	0.00181	0.00482	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—RELA—brain cancer	0.00175	0.00388	CbGpPWpGaD
Fluoxymesterone—Headache—Temozolomide—brain cancer	0.00175	0.00466	CcSEcCtD
Fluoxymesterone—Nausea—Carmustine—brain cancer	0.00172	0.00457	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.00169	0.00373	CbGpPWpGaD
Fluoxymesterone—Nausea—Temozolomide—brain cancer	0.00166	0.00442	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Etoposide—brain cancer	0.00165	0.00439	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00162	0.00358	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL2—brain cancer	0.00158	0.00349	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ABR—brain cancer	0.00157	0.00348	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.00157	0.00346	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CDKN2A—brain cancer	0.00156	0.00345	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CDK4—brain cancer	0.00155	0.00344	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00153	0.00339	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00152	0.00337	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GLI2—brain cancer	0.00152	0.00336	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—SKP2—brain cancer	0.00151	0.00335	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.0015	0.00332	CbGpPWpGaD
Fluoxymesterone—NR3C1—brain—brain cancer	0.0015	0.00897	CbGeAlD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.00149	0.00329	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GLI1—brain cancer	0.00143	0.00316	CbGpPWpGaD
Fluoxymesterone—Headache—Etoposide—brain cancer	0.0014	0.00373	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.0014	0.00309	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SUFU—brain cancer	0.00135	0.00299	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.00135	0.00298	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—STAT3—brain cancer	0.00133	0.00294	CbGpPWpGaD
Fluoxymesterone—Nausea—Etoposide—brain cancer	0.00133	0.00354	CcSEcCtD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CCND1—brain cancer	0.00132	0.00291	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GFAP—brain cancer	0.00131	0.00289	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00129	0.00286	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—APC—brain cancer	0.00129	0.00285	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.00128	0.00284	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.00127	0.00281	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.00126	0.00278	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.00126	0.00278	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00125	0.00276	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HEY1—brain cancer	0.00124	0.00274	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—DLL1—brain cancer	0.00121	0.00269	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.00121	0.00267	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.00121	0.00267	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.00119	0.00263	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.00118	0.00261	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00118	0.00261	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00115	0.00255	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—VAV1—brain cancer	0.00115	0.00255	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP2C9—brain cancer	0.00113	0.218	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—VAV1—brain cancer	0.00108	0.00239	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP2C9—brain cancer	0.00107	0.206	CrCbGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.00107	0.00236	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.00107	0.00236	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.00106	0.00235	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MYC—brain cancer	0.00106	0.00234	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00104	0.00231	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP2C9—brain cancer	0.00104	0.199	CrCbGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MYC—brain cancer	0.00104	0.00229	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CDKN2A—brain cancer	0.00104	0.00229	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SHH—brain cancer	0.00103	0.00228	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00103	0.00228	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.00102	0.00226	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.00102	0.00226	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.00101	0.00224	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.001	0.00222	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CCND1—brain cancer	0.001	0.00222	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000997	0.00221	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TRPC6—brain cancer	0.000995	0.0022	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000988	0.00219	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000983	0.00217	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTCH1—brain cancer	0.000978	0.00216	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SMO—brain cancer	0.000978	0.00216	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000969	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000961	0.00213	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000957	0.00212	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000952	0.0021	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PDGFRA—brain cancer	0.000944	0.00209	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—RELA—brain cancer	0.000944	0.00209	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000941	0.00208	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.000938	0.00207	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—ERBB2—brain cancer	0.000938	0.00207	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000929	0.00205	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—IL2—brain cancer	0.000919	0.00203	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000912	0.00202	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL2—brain cancer	0.000898	0.00199	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000897	0.00198	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CCND1—brain cancer	0.000896	0.00198	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PDGFRA—brain cancer	0.000885	0.00196	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000885	0.00196	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCND1—brain cancer	0.000876	0.00194	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000874	0.00193	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IRS2—brain cancer	0.000867	0.00192	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000867	0.00192	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000865	0.00191	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000862	0.00191	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000854	0.00189	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—brain cancer	0.000852	0.00188	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IRS2—brain cancer	0.000829	0.00183	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—brain cancer	0.000829	0.00183	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000819	0.00181	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000819	0.00181	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000811	0.00179	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.00081	0.00179	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000803	0.00178	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000793	0.00175	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000788	0.00174	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH2—brain cancer	0.000782	0.00173	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000779	0.00172	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IRS2—brain cancer	0.000777	0.00172	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000754	0.00167	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VAV1—brain cancer	0.000746	0.00165	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000742	0.00164	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000737	0.00163	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000736	0.00163	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000733	0.00162	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—brain cancer	0.000719	0.00159	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—STAT3—brain cancer	0.000715	0.00158	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—brain cancer	0.000703	0.00156	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000703	0.00155	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—brain cancer	0.000702	0.00155	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.000692	0.00153	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR2—brain cancer	0.000643	0.00142	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HES1—brain cancer	0.000641	0.00142	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000625	0.00138	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000615	0.00136	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000614	0.00136	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PDGFRA—brain cancer	0.000611	0.00135	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000609	0.00135	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000608	0.00135	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000607	0.00134	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000593	0.00131	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SPP1—brain cancer	0.000593	0.00131	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—OR4C12—brain cancer	0.000584	0.00129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—OR14C36—brain cancer	0.000584	0.00129	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—brain cancer	0.000577	0.00128	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000576	0.00127	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—RELA—brain cancer	0.000572	0.00127	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000572	0.00126	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—brain cancer	0.000569	0.00126	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000568	0.00126	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS2—brain cancer	0.000536	0.00119	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000536	0.00118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—brain cancer	0.000533	0.00118	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000522	0.00115	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—brain cancer	0.00052	0.00115	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—brain cancer	0.000515	0.00114	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000509	0.00113	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000504	0.00112	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.0005	0.00111	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—brain cancer	0.000498	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DTX2—brain cancer	0.000496	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—ESR2—brain cancer	0.000495	0.0011	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000493	0.00109	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	0.000488	0.00108	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000482	0.00107	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APC—brain cancer	0.000473	0.00105	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CG—brain cancer	0.000473	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000473	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000469	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000469	0.00104	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000462	0.00102	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—brain cancer	0.000454	0.001	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.00045	0.000995	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000444	0.000982	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000444	0.000982	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—brain cancer	0.000434	0.000959	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000413	0.000913	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000408	0.000903	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000405	0.000895	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000399	0.000884	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000396	0.000876	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—brain cancer	0.000394	0.000872	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000392	0.000868	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000388	0.000859	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.00038	0.00084	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTCH2—brain cancer	0.000376	0.000832	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000371	0.000821	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RELA—brain cancer	0.00037	0.000818	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—brain cancer	0.000369	0.000817	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—brain cancer	0.000368	0.000813	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HES5—brain cancer	0.000364	0.000806	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STRADA—brain cancer	0.000354	0.000782	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—DNMT1—brain cancer	0.000345	0.000763	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000342	0.000756	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000335	0.000742	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—brain cancer	0.000333	0.000737	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—brain cancer	0.000325	0.000718	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—brain cancer	0.000322	0.000712	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000315	0.000696	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000312	0.00069	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR2—brain cancer	0.00031	0.000685	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000308	0.000681	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ABR—brain cancer	0.000295	0.000653	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH2—brain cancer	0.000293	0.000649	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GLI2—brain cancer	0.000285	0.000631	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—brain cancer	0.000283	0.000626	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—brain cancer	0.00028	0.00062	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GLI1—brain cancer	0.000268	0.000593	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—DNMT1—brain cancer	0.000266	0.000588	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—DNMT1—brain cancer	0.000262	0.000579	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—brain cancer	0.000261	0.000576	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000258	0.000571	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—brain cancer	0.000255	0.000564	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SUFU—brain cancer	0.000254	0.000562	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SIRT1—brain cancer	0.000249	0.000552	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GFAP—brain cancer	0.000245	0.000542	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ESR2—brain cancer	0.000239	0.000528	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR2—brain cancer	0.000235	0.00052	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HEY1—brain cancer	0.000232	0.000514	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DLL1—brain cancer	0.000228	0.000504	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH2—brain cancer	0.000226	0.0005	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH2—brain cancer	0.000222	0.000492	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—brain cancer	0.000214	0.000473	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—brain cancer	0.000203	0.000449	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SHH—brain cancer	0.000194	0.000429	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SIRT1—brain cancer	0.000192	0.000425	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SIRT1—brain cancer	0.000189	0.000418	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TRPC6—brain cancer	0.000187	0.000413	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTCH1—brain cancer	0.000184	0.000406	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMO—brain cancer	0.000184	0.000406	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—brain cancer	0.000156	0.000346	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	0.000154	0.00034	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH2—brain cancer	0.000147	0.000325	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VAV1—brain cancer	0.00014	0.00031	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HES1—brain cancer	0.00012	0.000266	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFRA—brain cancer	0.000115	0.000254	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SPP1—brain cancer	0.000111	0.000246	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS2—brain cancer	0.000101	0.000223	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—brain cancer	9.77e-05	0.000216	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APC—brain cancer	8.89e-05	0.000197	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—brain cancer	8.89e-05	0.000197	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—brain cancer	7.52e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—brain cancer	7.41e-05	0.000164	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RELA—brain cancer	6.95e-05	0.000154	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—brain cancer	6.9e-05	0.000153	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—brain cancer	6.26e-05	0.000138	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—brain cancer	6.1e-05	0.000135	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—brain cancer	6.04e-05	0.000134	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—brain cancer	5.32e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—brain cancer	5.26e-05	0.000116	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—brain cancer	4.89e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—brain cancer	4.78e-05	0.000106	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—brain cancer	4.02e-05	8.89e-05	CbGpPWpGaD
